Novel human genetic variants associated with extrapulmonary tuberculosis: A pilot genome wide association study

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Oki, Noffisat O ^a   Motsinger Reif, Alison A ^a   Antas, Paulo R Z ^b   Levy, Shawn ^b   Holland, Steven M ^c   Sterling, Timothy R ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

EID: 79251535007     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-28     Document Type: Article

References (51)

1. Raviglione MC, Snider DE, Kochi A: Global Epidemiology of Tuberculosis Morbidity and Mortality of a worldwide epidemic. JAMA 1995, 273:220-226.
2. Horsburgh CR: Priorities for the treatment of latent tuberculosis in the United States. NEJM 2004, 350(3):2060-2067.
3. Centers for Disease Control and Prevention: Decrease in Reported Tuberculosis Cases - United States, 2009. MMWR 2010, 59:289-94.
4. World Health Organisation: Global tuberculosis control: a short update to the 2009 report. WHO/HTM/TB/2009.426 .
5. American Thoracic Society: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000, 161(4 Suppl):221-247.
6. Stein CM, Guwatudde D, Nakakeeto M, Peters P, Elston RC, Tiwari HK, Mugerwa R, Whalen CC: Heritability analysis of cytokines as intermediate phenotypes of tuberculosis. J Infect Dis 2003, 187(11):1679-85. (Pubitemid 36667877)
7. Stein CM, Nshuti L, Chiunda AB, Boom WH, Elston RC, Mugerwa RD, Iyengar SK, Whalen CC: Evidence for a major gene influence on tumor necrosis factor-alpha expression in tuberculosis: path and segregation analysis. Hum Hered 2005, 60(2):109-18. (Pubitemid 41540638)
8. Berrington WR, Hawn TR: Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunol Rev 2007, 219:1671-186.
9. Bellamy R, Beyers N, McAdam KP, Ruwende C, Gie R, Samaai P, Bester D, Meyer M, Corrah T, Collin M, Camidge DR, Wilkinson D, Helden EH, Whittle HC, Amos W, Helden P, Hill AVS: Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci USA 2000, 97:8005-8009. (Pubitemid 30460763)
10. Fitness J, Floyd S, Warndorff DK, Sichali L, Malema S, Crampin AC, Fine PE, Hill AV: Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 2004, 71(3):330-340. (Pubitemid 39223511)
11. Miller EN, Jamieson SE, Joberty C, Fakiola M, Hudson D, Peacock C S, Cordell H J, Shaw M-A, Lins-Lainson Z, Shaw J J, Ramos F, Silveira F, Blackwell J M: Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes and Immunity 2004, 5:63-67.
12. Comstock GW: Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Resp Dis 1978, 117:621-624.
13. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV: Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 1998, 79:83-89. (Pubitemid 29078276)
14. Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Whittle HC, Hill AVS: Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998, 338:640-644. (Pubitemid 28108433)
15. Awomoyi AA, Marchant A, Howson JM, McAdam KP, Blackwell JM, Newport MJ: Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 2002, 186:1808-1814. (Pubitemid 35463514)
16. Bellamy R, Ruwende C, Corrah T, McAdam KP, Thursz M, Whittle HC, Hill AV: Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999, 179:721-724. (Pubitemid 30016163)
17. Hasan Z, Zaidi I, Jamil B, Khan MA, Kanji A, Hussain R: Elevated ex viv monocyte chemotactic protein-1 (CCL2) in pulmonary as compared to extra-pulmonary tuberculosis. BMC Immunol 2005, 6:14.
18. Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, Cave MD, Bates JH: Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 2004, 38(2):199-205. (Pubitemid 38113027)
19. Gonzalez OY, Adams G, Teeter LD, Bui TT, Musser JM, Graviss EA: Extrapulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis 2003, 7:1178-1185. (Pubitemid 38004742)
20. Antas PRZ, Ding L, Hackman J, Reeves-Hammock L, Shintani AK, Schiffer J, Holland SM, Sterling TR: Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis. J Allerg Clin Immunol 2006, 117:916-923.
21. Sterling TR, Dorman SE, Chaisson RE, Ding L, Hackman J, Moore K, Holland SM: HIV- seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses. Clin Infect Dis 2001, 33:976-982. (Pubitemid 32907098)
22. Fernando SL, Saunders BM, Sluyter R, Skarratt Kk, Goldberg H, Marks GB, Wiley JS, Britton WJ: A polymorphism in the P2X7 Gene Increases Susceptibility to extrapulmonary tuberculosis. Am J Respir Crit Care Med 2006, 175:360-366.
23. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, Wright D, Latif M, Davidson RN: Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati asians in west London: a case-control study. Lancet 2000, 355(9204):618-621. (Pubitemid 30099469)
24. Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, Davidson RN, Toossi Z: Influence of polymorphisim in the genes for the interleukin (IL)-1 Receptor antagonist an IL-1β on tuberculosis. J Exp Med 1999, 189(12):1863-1874.
25. Taype CA, Shamsuzzaman S, Accinelli RA, Espinoza JR, Shaw M: Genetic susceptibility to different clinical forms of tuberculosis in the peruvian population. Infection Genetics and Evolution 2010, 5(10(4)):495-504.
26. Tso HW, Ip WK, Chong WP, Tam CM, Chiang AK, Lau YL: Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 2005, 6(4):358-63. (Pubitemid 40903409)
27. Mosaad OE, Soliman ZE, Tawhid D, Sherif DM: Interferon-gamma +874 T/A and Interleukin-10 -1082 A/G Single nucleotide Polymorphism in Egyptian Children with Tuberculosis. Scandinavian J of Immun 2010, 72(4):358-364.
28. Ansari A, Talat N, Jamil B, Hasan Z, Razzaki T, Dawood G, Hussain R: Cytokine gene polymorphisms across tuberculosis clinical spectrum in Pakistani patients. PLoS One 2009, 4(3):e4778.
29. Henao MI, Montes C, París SC, García LF: Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis (Edinb) 2006, 86(1):11-9. (Pubitemid 41797654)
30. Motsinger-Reif AA, Antas PRZ, Oki NO, Levy S, Holland SM, Sterling TR: Polymorphisms in IL-1, Vitamin D Receptor Fok1, and Toll-like Receptor 2 are Associated with Extrapulmonary Tuberculosis. BMC Med Genet 2010, 2:11-37.
31. Purcell s, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, DeBakker PI, Daly MJ, Sham PC: PLINK, a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-75.
32. Marchini J, Cardon LR, Phillips MS, Donnelly P: The effects of human population structure on large genetic association studies. Nat Genet 2004, 36(5):512-7. (Pubitemid 38620038)
33. Freedman M, Reich D, Penney K, J McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D: Assessing the impact of population stratification on genetic association studies. Nat Genet 2004, 36:388-393. (Pubitemid 38437262)
34. Helgason A, Yngvadóttir B, Hrafnkelsson B, Gulcher J, Stefánsson K: An Icelandic example of the impact of population structure on association studies. Nat Genet 2005, 37:90-95. (Pubitemid 40070945)
35. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D: Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909. (Pubitemid 44141658)
36. Patterson N, Price AL, Reich D: Population Structure and Eigenanalysis. PLoS Genet 2006, 2(12):e190.
37. Ge D, Zhang K, Need AC, Martin O, Fellay J, Urban TJ, Telenti A, Golsteing DB: WGAViewer: software for genomic annotation of whole genome asociation studies. Genome Res 2008, 18:640-643. (Pubitemid 351482788)
38. Hubbard TJP, Aken BL, Ayling S, Ballester B, Beal K, Bragin E, Brent S, Chen Y, Clapham P, Clarke L, Coates G, Fairley S, Fitzgerald S, Fernandez-Banet J, Gordon L, Gräf S, Haider S, Hammond M, Holland R, Howe K, Jenkinson A, Johnson N, Kähäri A, Keefe D, Keenan S, Kinsella R, Kokocinski F, Kulesha E, Lawson D, Longden I, Megy K, Meidl P, Overduin B, Parker A, Pritchard B, Rios D, Schuster M, Slater G, Smedley D, Spooner W, Spudich G, Trevanion S, Vilella A, Vogel J, White S, Wilder S, Zadissa A, Birney E, Cunningham F, Curwen V, Durbin R, Fernandez-Suarez XM, Herrero J, Kasprzyk A, Proctor G, Smith J, Searle S, Flicek P: Ensembl 2009. Nucleic Acids Research 2009, , 37 Database: D690-D697.
39. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG: Replication validity of genetic association studies. Nat Genet 2002, 29(3):306-309.
40. Wang TH, Wang HS: A genome-wide association study primer for clinicians. Taiwan J Obstet Gynecol 2009, 48(2):89-95.
41. Good P: Extensions of the concept of exchangeability and their applications. J Modern Appl Statist Methods 2002, 1:4.
42. Raymond M, Rousset F: Genepop (version1.2): population genetics software for exact tests and ecumenicism. J Hered 1995, 86(3):248.
43. Kelly MO, Logue SF, Brennan J, Day JP, Lakkaraju S, Jiang L, Zhong X, Tam M, Sukoff SJRizzo, Platt BJ, Dwyer JM, Neal S, Pulito VL, Agostino MJ, Grauer SM, Navarra RL, Kelley C, Comery TA, Murrills RJ, Houslay MD, Brandon NJ: Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes. Proc Natl Acad Sci 2010, 107(18):8457-62.
44. National Center for Biotechnology Information (NCBI) Entrez Gene. [http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene].
45. Alagramam KN, Yuan H, Kuehn MH, Murcia CL, Wayne S, Srisailpathy CRS, Lowry RB, Knaus R, Van LL, Bernier FP, Schwartz S, Lee C, Morton CC, Mullins RF, Ramesh A, Van Camp G, Hagemen GS, Woychik RP, Smith RJH: Mutations in the novel protocadherin PCDH15 cause usher syndrome type 1F. Human Molecular Genetics 2001 August 01, 10(16):1709-18. (Pubitemid 32776301)
46. Tochio N, Koshiba S, Kobayashi N, Inoue M, Takashi MA, Seki E, Matsuda T, Tomo Y, Motoda Y, Kobayashi A, Tanaka A, Hayashizaki Y, Terada T, Shirouzu M, Kigawa T, Yokoyama S: Solution structure of the kinase-associated domain 1 of mouse microtubule- associated protein/microtubule affinity-regulating kinase 3. Protein Sci 2006 November, 15(11):2534-2543. (Pubitemid 44771690)
47. Shyur S, Wang J, Lin CG, Hsiao Y, Liou Y, Wu Y, Wu LS: The polymorphisms of protein-tyrosine phosphatase receptor-type delta gene and its association with pediatric asthma in the taiwanese population. Eur J Hum Genet 2008, 16(10):1283-8.
48. Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P, Ripke S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Hogl B, Frauscher B, Gschliesser V, Poewe W, Peglau I, Vodicka P, Vavrova J, Sonka K, Nevsimalova S, Montplaisir J, Turecki G, Rouleau G, Gieger C, Illig T, Wichmann H, Holsboer F, Muller-Myhsok B, Meitinger T, Winkelmann J: PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 2008, 40(8):946-8.
49. Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB, Paty PB, Rohle D, Vivanco I, Chmielecki J, Pao W, Ladanyi M, Gerald WL, Liau L, Cloughesy TC, Mischel PS, Sander C, Taylor B, Schultz N, Major J, Heguy A, Fang F, Mellinghoff IK, Chan TA: The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proceedings of the National Academy of Sciences 2009 June 09, 106(23):9435-40.
50. Nishimura M, Suzuki S, Satoh T, Naito S: Tissue-Specific mRNA Expression Profiles of Human Solute Carrier 35 Transporters. Drug Metabolism and Pharmacokinetics 2009, 24(1):91-9.
51. Shi YY, Zhao XZ, Yu L, Tao R, Tang J, La Y, Duan Y, Gao B, Gu N, Xu Y, Feng G, Zhu S, Liu H, Salter H, He L: Genetic Structure Adds Power to Detect Schizophrenia Susceptibility at SLIT3 in the Chinese Han Population. Genome Res 2004, 14(7):1345-1349. (Pubitemid 39029231)